The Dapivirine vaginal ring (DPV-VR) is an intravaginal silicone ring that delivers an antiretroviral drug (Dapivirine) directly to vaginal tissues for 28 days. This ring protects women against HIV during the receptive vaginal sex at the site of potential infection. In 2021. the WHO recommended DPV as an additional prevention method for high-risk women for HIV with other approaches. https://qpituzo7kj8o.timeblog.net/70682801/drawing-skills-at-the-beginning-of-higher-education-teachers-perspectives-expectations-and-realities